Literature DB >> 19878868

PARsing the phrase "all in for Axin"- Wnt pathway targets in cancer.

Eric R Fearon1.   

Abstract

Genetic alternations resulting in constitutive stabilization of beta-catenin and altered transcription of beta-catenin/TCF-regulated genes are found in many cancers. A recent Nature paper offers insights into the role of tankyrase in regulating the Wnt/beta-catenin pathway and suggests that compounds targeting tankyrase's poly-ADP-ribosylation (PARsylation) activity may hold promise for cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19878868     DOI: 10.1016/j.ccr.2009.10.007

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  17 in total

1.  Micromanaging the classification of colon cancer: the role of the microRNAome.

Authors:  Eduardo Vilar; Josep Tabernero; Stephen B Gruber
Journal:  Clin Cancer Res       Date:  2011-10-21       Impact factor: 12.531

2.  Tankyrase is necessary for canonical Wnt signaling during kidney development.

Authors:  Courtney M Karner; Calli E Merkel; Michael Dodge; Zhiqiang Ma; Jianming Lu; Chuo Chen; Lawrence Lum; Thomas J Carroll
Journal:  Dev Dyn       Date:  2010-07       Impact factor: 3.780

3.  Crystal structure of a Tankyrase-Axin complex and its implications for Axin turnover and Tankyrase substrate recruitment.

Authors:  Seamus Morrone; Zhihong Cheng; Randall T Moon; Feng Cong; Wenqing Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

Review 4.  Ring finger protein 146/Iduna is a poly(ADP-ribose) polymer binding and PARsylation dependent E3 ubiquitin ligase.

Authors:  Zhi-dong Zhou; Christine Hui-shan Chan; Zhi-cheng Xiao; Eng-king Tan
Journal:  Cell Adh Migr       Date:  2011 Nov-Dec       Impact factor: 3.405

5.  Regulation of the DLG tumor suppressor by β-catenin.

Authors:  Vanitha Krishna Subbaiah; Nisha Narayan; Paola Massimi; Lawrence Banks
Journal:  Int J Cancer       Date:  2012-03-28       Impact factor: 7.396

Review 6.  Therapeutic potential of cancer stem cells.

Authors:  Chunguang Yang; Kunlin Jin; Yangping Tong; William Chi Cho
Journal:  Med Oncol       Date:  2015-04-25       Impact factor: 3.064

Review 7.  Emerging role of the β-catenin-PPARγ axis in the pathogenesis of colorectal cancer.

Authors:  Lina Sabatino; Massimo Pancione; Carolina Votino; Tommaso Colangelo; Angelo Lupo; Ettore Novellino; Antonio Lavecchia; Vittorio Colantuoni
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

8.  The Poly(ADP-ribose) Polymerase Enzyme Tankyrase Antagonizes Activity of the β-Catenin Destruction Complex through ADP-ribosylation of Axin and APC2.

Authors:  Heather E Croy; Caitlyn N Fuller; Jemma Giannotti; Paige Robinson; Andrew V A Foley; Robert J Yamulla; Sean Cosgriff; Bradford D Greaves; Ryan A von Kleeck; Hyun Hyung An; Catherine M Powers; Julie K Tran; Aaron M Tocker; Kimberly D Jacob; Beckley K Davis; David M Roberts
Journal:  J Biol Chem       Date:  2016-04-11       Impact factor: 5.157

9.  Inhibition of tankyrases induces Axin stabilization and blocks Wnt signalling in breast cancer cells.

Authors:  Renyue Bao; Tania Christova; Siyuan Song; Stephane Angers; Xiaojun Yan; Liliana Attisano
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

10.  FH535 inhibited metastasis and growth of pancreatic cancer cells.

Authors:  Meng-Yao Wu; Rong-Rui Liang; Kai Chen; Meng Shen; Ya-Li Tian; Dao-Ming Li; Wei-Ming Duan; Qi Gui; Fei-Ran Gong; Lian Lian; Wei Li; Min Tao
Journal:  Onco Targets Ther       Date:  2015-07-06       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.